Michael Dobryansky, MD
Plastic Surgery · Garden City, NYNPI 1073636908
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.5%), food and beverage and grants — rather than concentrated in one kind of arrangement. Merz North America, Inc. accounts for 62.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $4,936 and has fallen 90.3% since, to $481 in 2025.
Across 81 payments — averaging $214.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$11K
- AbbVie$4K
- Sientra, Inc.$979
- Davol Inc.$469
- Galderma Laboratories, L.p.$442
- Smith+Nephew$212
- plus $642 from 10 others
Across 4 payments — averaging $2706.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merz North America, Inc.$11K
What the payments were for
- Consulting fees$9,81857%
- Speaking & faculty fees$6794%
- Grants$2,09512%
- Food & beverage$4,01423%
- Education$7694%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 14 | $10,788 |
| AbbVie(2 entities) | 22 | $3,842 |
| Sientra, Inc. | 10 | $979 |
| Davol Inc. | 4 | $469 |
| Galderma Laboratories, L.p. | 7 | $442 |
| Smith+Nephew | 12 | $212 |
| Teleflex LLC | 2 | $132 |
| Organogenesis Inc. | 1 | $122 |
| Johnson & Johnson | 1 | $120 |
| TELA Bio, Inc. | 1 | $90 |
| Integra Lifesciences Corporation | 2 | $56 |
| Stryker | 1 | $34 |
| Mentor Worldwide LLC | 1 | $32 |
| Apyx Medical Corporation | 1 | $22 |
| Tepha Inc | 1 | $20 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$854
- REVOLVE$714
- NATRELLE SALINE-FILLED BREAST IMPLANTS$714
- ALLODERM$667
- Phasix Mesh$433
- BOTOX$150
- DYSPORT$132
- PuraPly$122
- XARELTO$120
- QuikClot$110
How this compares
$17,374 in reported general payments places this provider in the 85th percentile of 363 plastic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic surgery in Garden City
- Richard ReishGarden City$115K
- Tommaso AddonaGarden City$23K
- David ParizhGarden City$10K
- Sachin ShridharaniNew York$1.1M
- Scot GlasbergNew York$959K
- Nolan KarpNew York$900K
- Michael LacquaBrooklyn$865K
- Sydney ColemanNew York$729K
- David RapaportNew York$578K
- Richard SwiftNew York$487K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.